MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical and epidemiological data on Parkinson’s disease in older adults: experience of a single Italian centre.

T. Schirinzi, G. Di Lazzaro, M. Pierantozzi, A. Stefani, N. Mercuri, A. Pisani (Rome, Italy)

Meeting: 2019 International Congress

Abstract Number: 1834

Keywords: Aging

Session Information

Date: Wednesday, September 25, 2019

Session Title: Epidemiology

Session Time: 1:15pm-2:45pm

Location: Les Muses, Level 3

Objective: To provide descriptive data on clinical features and therapy of older patients with PD (OPD) from an Italian single centre.

Background: The incidence of neurodegenerative diseases, such as Parkinson’s disease (PD), is expected to increase significantly in the next future, with relevant socio-economic implications. OPD represent a category of extreme frailty, presenting higher burden of comorbidities, multiple therapies and different sensitivity to medications . Despite the relevance of this matter, clinical-epidemiological studies lack, although they are essential to drive public health’s choices.

Method: This cross-sectional study retrospectively evaluated over a 7 years long period a group of OPD patients afferent to Tor Vergata University Hospital (Rome, Italy) that at last visit was older than 75 years. Data on age, sex, disease duration, Hoehn and Yahr (H&Y) score, presence of depression, cognitive decline, hallucinations, levodopa induced dyskinesia (LID) and current therapy were collected. Descriptive statistics, parametric test and regression analysis were performed.

Results: 916 PD patients were reviewed and 240 case have been included in the study (61%male) with a mean±SD H&Y score = 2.23±1. Prevalence of depression, cognitive decline, hallucinations and LID were calculated, resulting LID significantly more frequent in male.  The mean±SD levodopa equivalent dose (LED) was 713±358 mg/day. Levodopa (LD) was the largest used medication (>95% of population); dopamine agonists (DA) were administrated in 39.3% and MAO inhibitors (IMAO) in 28.5%. Frequencies of either mono-/multiple therapies or single medication from DA and IMAO groups were calculated together with concomitant other therapies. No significant associations emerged between different therapeutic regimens and clinical complications.

Conclusion: This study provides preliminary clinical-epidemiological data on Italian OPD. Of interest, they may constitute the background for future interventions aimed at improving the health status of a rapidly growing frail patient category.

To cite this abstract in AMA style:

T. Schirinzi, G. Di Lazzaro, M. Pierantozzi, A. Stefani, N. Mercuri, A. Pisani. Clinical and epidemiological data on Parkinson’s disease in older adults: experience of a single Italian centre. [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/clinical-and-epidemiological-data-on-parkinsons-disease-in-older-adults-experience-of-a-single-italian-centre/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-and-epidemiological-data-on-parkinsons-disease-in-older-adults-experience-of-a-single-italian-centre/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley